Trials / Not Yet Recruiting
Not Yet RecruitingNCT06112041
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors(PRaG9.0)
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 29 (estimated)
- Sponsor
- Second Affiliated Hospital of Soochow University · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single-arm, Phase II investigator-initiated trial of hypofractionated radiotherapy combined with PD-L1 inhibitor sequential GM-CSF and thymopentin for treatment of elderly patients with advanced solid tumors, when the HER-2 positive patients are treated with extra antibody-drug conjugate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin | RC48-ADC combined with hypofractionated radiotherapy, PD-L1 inhibitor sequential GM- CSF and Thymopentin |
Timeline
- Start date
- 2023-10-25
- Primary completion
- 2026-10-30
- Completion
- 2026-10-30
- First posted
- 2023-11-01
- Last updated
- 2023-11-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06112041. Inclusion in this directory is not an endorsement.